乳腺癌（英文版）

Epidemiology of Breast Cancer

Epidemiology and prognosis of breast cancer in young women

Lack of patient-reported outcomes assessment in phase III breast cancer studies： a missed opportunity for informed decision making

Advances in Basic Research of Breast Cancer

Breast cancer in the young： role of the geneticist

An update on the genomic landscape of breast cancer： new opportunity for personalized therapy?

Towards the elucidation of the mechanisms underlying breast cancer mutations

Members of the BRCA1 complexes as new susceptibility genes for breast cancer

APOBEC3B spreads somatic mutations in breast cancer genome

From genomic data analysis to drug development： a new generation of trials using molecular marker assessment in breast cancer

MET deregulation in breast cancer

Circulating free DNA in the management of breast cancer

Imaging Examination of Breast Cancer

Breast imaging in the young： the role of magnetic resonance imaging in breast cancer screening，diagnosis and follow-up

Treatment of Breast Cancer

Challenges in managing breast cancer during pregnancy

Premature menopause in young breast cancer： effects on quality of life and treatment interventions

Surgical Treatment

Conservative mastectomies for breast cancer and risk-reducing surgery： the Memorial Sloan Kettering Cancer Center experience

Oncoplastic techniques in breast surgery for special therapeutic problems

Oncological safety of prophylactic breast surgery： skin-sparing and nipple-sparing versus total mastectomy

Anatomy relevant to conservative mastectomy

Breast reconstruction following conservative mastectomies： predictors of complications and outcomes

Surgical management of breast cancer in China： the Fudan University Shanghai Cancer Center experience

Endocrine Therapy

Paradigm of polyendocrine therapy in endocrine responsive breast cancer： the role of fulvestrant

Bisphosphonates in the adjuvant treatment of young women with breast cancer： the estrogen rich is a poor candidate！

Hormonal therapies in young breast cancer patients： when， what and for how long?

A balancing act for breast cancer? Everolimus for hormone receptor positive patients

Chemotherapy

Treatment of breast cancer in young women： do we need more aggressive therapies?

Neoadjuvant bevacizumab and chemotherapy in breast cancer

Radiotherapy

Impact of preoperative magnetic resonance imaging in breast cancer patients candidates for an intraoperative partial breast irradiation

First year experience with IORT for breast cancer at the Geneva University Hospitals

CyberKnife stereotaetie body radiotherapy and CyberKnife aeeelerated partial breast irradiation for the treatment of early breast cancer

Brest experience in intraoperative radiotherapy for breast cancer

Intraoperative radiotherapy with electrons （ELIOT） for early breast cancer： the European Institute of Oneology experience

Comparison of the proliferative and elonogenie growth capacity of wound fluid from breast cancer patients treated with and without intraoperative radiotherapy

The use of postoperative radiation after nipple sparing mastectomy

Optimal management of sentinel lymph node positive biopsy patients in early breast cancer

Targeted Therapy

Should trastuzumab be administered concomitantly with anthracycline in women with early， HER2-positive breast cancer?

Pertuzumab in metastatic breast cancer： unanswered questions

Pertuzumab： a step forward in treating HER2-positive breast cancer

Bevacizumab： Where do we go from here in breast cancer?

Lapatinib as a therapeutic option in brain metastases from HER2+ breast cancer

The ALTERNATE trial： assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2- invasive breast cancer

Nanoparticle Therapy

Theranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancer

Prognosis of Breast Cancer

Fertility counseling of young breast cancer patients

Sexuality and breast cancer： prime time for young patients

Breast cancer and sleep disturbance： more than simply a quality of life concern

Brain metastases in HER2 positive breast cancer： the next hurdle

Brain metastases in HER2-positive breast cancer： challenges and opportunities